Michael Chorny

Title: Michael Chorny: Innovator in Nanoparticle Technology

Introduction

Michael Chorny is a prominent inventor based in Jerusalem, Israel. He is known for his groundbreaking work in the field of nanoparticle technology, particularly in the delivery of nucleic acids into living cells. His innovative approach has the potential to significantly impact pharmaceutical applications.

Latest Patents

Michael Chorny holds a patent for "Nanoparticles containing polymeric nucleic acid homologs." This invention describes a nanoparticle capable of delivering an encapsulated molecule into a living cell. The nanoparticle includes an encapsulation media and an isolated nucleic acid homolog sequence. The encapsulation media is primarily polymeric, allowing for the release of the encapsulated molecule over an extended period of time. The patent also discloses pharmaceutical compositions and articles of manufacture that include these nanoparticles, along with methods for preparing and using them.

Career Highlights

Chorny is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop innovative solutions in the field of drug delivery systems. His contributions have been recognized within the scientific community, showcasing his commitment to advancing medical technology.

Collaborations

Michael Chorny has collaborated with notable colleagues, including Gershon Golomb and Haigt Sacks. These partnerships have fostered a collaborative environment that enhances the research and development of nanoparticle technologies.

Conclusion

Michael Chorny is a significant figure in the realm of nanoparticle technology, with a focus on enhancing drug delivery systems. His innovative patent and collaborations highlight his dedication to advancing the field. His work continues to pave the way for future developments in pharmaceutical applications.